Morbus Alzheimer - Rivastigmine: Approval for the first transdermal application granted in Europe

被引:0
|
作者
不详
机构
来源
NERVENARZT | 2007年 / 78卷 / 10期
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A1 / A3
页数:3
相关论文
共 50 条
  • [1] Rivastigmine transdermal system receives FDA approval for Alzheimer's disease
    Ralat, Jose
    CNS SPECTRUMS, 2007, 12 (08) : 581 - 582
  • [2] Visual Hallucinations Due to Rivastigmine Transdermal Patch Application in Alzheimer's Disease; The First Case Report
    Degirmenci, Yildiz
    Kececi, Hulusi
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2016, 10 (04) : 240 - 241
  • [4] Rivastigmine Transdermal PatchIn the Treatment of Dementia of the Alzheimer’s Type
    Lily P. H. Yang
    Gillian M. Keating
    CNS Drugs, 2007, 21 : 957 - 965
  • [5] Spotlight on Rivastigmine Transdermal PatchIn Dementia of the Alzheimer’s Type
    Sohita Dhillon
    Drugs & Aging, 2011, 28 : 927 - 930
  • [7] Use of rivastigmine transdermal patch in the treatment of Alzheimer's disease
    Winblad, Bengt
    Machado, Joao Carlos
    EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (12) : 1377 - 1386
  • [8] Spotlight on Rivastigmine Transdermal Patch In Dementia of the Alzheimer's Type
    Dhillon, Sohita
    DRUGS & AGING, 2011, 28 (11) : 927 - 930
  • [9] Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease
    Emre, Murat
    Bernabei, Roberto
    Blesa, Rafael
    Bullock, Roger
    Cunha, Luis
    Daniels, Hugo
    Dziadulewicz, Edward
    Foerstl, Hans
    Froelich, Lutz
    Gabryelewicz, Tomasz
    Levin, Oleg
    Lindesay, James
    Martinez-Lage, Pablo
    Monsch, Andreas
    Tsolaki, Magda
    van Laar, Teus
    CNS NEUROSCIENCE & THERAPEUTICS, 2010, 16 (04) : 246 - 253
  • [10] Tolerability of rivastigmine transdermal patch in Alzheimer dementia with psychotic features
    Vasile, D.
    Vasiliu, O.
    Vasile, M.
    Terpan, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S622 - S623